A Randomised, Double-blind, Placebo-controlled, Dose Ascending, 3-way Crossover Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2017
At a glance
- Drugs GSK 870086 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Acronyms SIG
- Sponsors GlaxoSmithKline
- 19 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 19 Nov 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2010 New trial record